CRO

Closed closing shuttering out of business going out of business

AmplifyBio shutters amid tough cell and gene therapy market

On the heels of a recent cost-cutting drive that severed much of AmplifyBio’s R&D capacity, the cell and gene contractor has hung up its hat for good.

Fraiser Kansteiner Apr 7, 2025 10:38am

tariffs duties taxes trade trade policy Trump

Drugmakers sound alarm on possible Trump tariff impacts

Mar 26, 2025 5:12pm

A graphic from Ora and BlindCANs work on The Blind Canvas Project in collaboration with the Academy of Music for the Blind

CRO Ora showcases key role music plays in the blind community

Dec 12, 2024 10:35am

Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together

House Speaker pledges support for China-targeting BIOSECURE Act

Jul 9, 2024 8:56am

Eisai, Takeda, BIOSECURE Act—Fierce Pharma Asia

May 17, 2024 8:30am